Literature DB >> 21939729

Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.

Adel Helmy1, Maria-Grazia De Simoni, Mathew R Guilfoyle, Keri L H Carpenter, Peter J Hutchinson.   

Abstract

There is an increasing recognition that following traumatic brain injury, a cascade of inflammatory mediators is produced, and contributes to the pathological consequences of central nervous system injury. This review summarises the key literature from pre-clinical models that underlies our understanding of innate inflammation following traumatic brain injury before focussing on the growing evidence from human studies. In addition, the underlying molecular mediators responsible for blood brain barrier dysfunction have been discussed. In particular, we have highlighted the different sampling methodologies available and the difficulties in interpreting human data of this sort. Ultimately, understanding the innate inflammatory response to traumatic brain injury may provide a therapeutic avenue in the treatment of central nervous system disease. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939729     DOI: 10.1016/j.pneurobio.2011.09.003

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  89 in total

Review 1.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 2.  How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury.

Authors:  Denes V Agoston; Robert Vink; Adel Helmy; Mårten Risling; David Nelson; Mayumi Prins
Journal:  J Neurotrauma       Date:  2019-03-07       Impact factor: 5.269

3.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

Review 4.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

5.  Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes.

Authors:  Mahmoud L Soliman; Colin K Combs; Thad A Rosenberger
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-12       Impact factor: 4.147

6.  A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent.

Authors:  Jana Portnow; Behnam Badie; Xueli Liu; Paul Frankel; Shu Mi; Mike Chen; Timothy W Synold
Journal:  J Neurooncol       Date:  2014-03-15       Impact factor: 4.130

7.  Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury.

Authors:  Edward J Goetzl; Fanny M Elahi; Maja Mustapic; Dimitrios Kapogiannis; Moira Pryhoda; Anah Gilmore; Kimberly A Gorgens; Bradley Davidson; Anne-Charlotte Granholm; Aurélie Ledreux
Journal:  FASEB J       Date:  2019-01-03       Impact factor: 5.191

Review 8.  Traumatic brain injury, neuroinflammation, and post-traumatic headaches.

Authors:  Cynthia L Mayer; Bertrand R Huber; Elaine Peskind
Journal:  Headache       Date:  2013-07-08       Impact factor: 5.887

9.  Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.

Authors:  Luca Longhi; Carlo Perego; Fabrizio Ortolano; Silvia Aresi; Stefano Fumagalli; Elisa R Zanier; Nino Stocchetti; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

10.  Increased expression of ferritin in cerebral cortex after human traumatic brain injury.

Authors:  Huan-Dong Liu; Wei Li; Zhen-Rui Chen; Meng-Liang Zhou; Zong Zhuang; Ding-Ding Zhang; Lin Zhu; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2012-10-19       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.